Related Experiment Video
Updated: Nov 19, 2025
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Evaluatıon of adverse events following immunization reported during national immunization programs (Between 2017-2019
A Çigdem Simsek1, Elif Arabulan1, Nilufer Tavukçu1
1Ankara Provincial Health Directorate, Ankara, Turkey.
Vaccination services are important in primary health-care service. The Expanded Programme on Immunization (EPI) began in 1981 in Turkey. Vaccines are generally safe products; although rare, undesirable effects may be observed after vaccination. In order to increase vaccination rates, vaccine acceptability and service quality; the Vaccine Adverse Event Reporting System (VAERS) and performing necessary interventions are indispensable parts of vaccination programs. This study aimed to evaluate Adverse Events Following Immunization (AEFI) cases during 2017-2019 in Ankara. A total of ~1.7 million doses of vaccine were administered, and only 71 adverse events following immunization (AEFI) were reported (0.41 cases/million doses of risk). AEFI forms were examined, and of these 71 cases, 17 (24%) were hospitalized and 54 (76%) were followed-up.
Vaccination services are important in primary health-care service. The Expanded Programme on Immunization (EPI) began in 1981 in Turkey. Vaccines are generally safe products; although rare, undesirable effects may be observed after vaccination. In order to increase vaccination rates, vaccine acceptability and service quality; the Vaccine Adverse Event Reporting System (VAERS) and performing necessary interventions are indispensable parts of vaccination programs. This study aimed to evaluate Adverse Events Following Immunization (AEFI) cases during 2017-2019 in Ankara. A total of ~1.7 million doses of vaccine were administered, and only 71 adverse events following immunization (AEFI) were reported (0.41 cases/million doses of risk). AEFI forms were examined, and of these 71 cases, 17 (24%) were hospitalized and 54 (76%) were followed-up.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:51Vaccinations